{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:00:52Z","timestamp":1790074852943,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.forsciint.2025.112794","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:56:31Z","timestamp":1767113791000},"page":"112794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Nitazene-related deaths in Norway 2021\u20132024"],"prefix":"10.1016","volume":"380","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9717-9913","authenticated-orcid":false,"given":"Merete","family":"Vevelstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege-Merete","family":"Krabseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Magritt","family":"Haneborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Ole M.","family":"Gundersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5se Marit Leere","family":"\u00d8iestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2025.112794_bib1","unstructured":"World Drug Report 2025. Key findings: United Nations Office on Drugs and Crime (UNODC); [Available from: \u3008https:\/\/www.unodc.org\/documents\/data-and-analysis\/WDR_2025\/WDR25_B1_Key_findings.pdf\u3009."},{"key":"10.1016\/j.forsciint.2025.112794_bib2","unstructured":"European Drug Report 2025: Trends and Developments. New psychoactive substances: European Union Drugs Agency (EUDA); [Available from: \u3008https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2025\/new-psychoactive-substances_en\u3009."},{"issue":"7","key":"10.1016\/j.forsciint.2025.112794_bib3","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1021\/acschemneuro.1c00037","article-title":"DARK classics in chemical neuroscience: etonitazene and related benzimidazoles","volume":"12","author":"Ujv\u00e1ry","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.forsciint.2025.112794_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110470","article-title":"Navigating nitazenes: a pharmacological and toxicological overview of new synthetic opioids with a 2-benzylbenzimidazole core","author":"Vandeputte","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.forsciint.2025.112794_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.858234","article-title":"Synthetic benzimidazole opioids: the emerging health challenge for European drug users","volume":"13","author":"Di Trana","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.forsciint.2025.112794_bib6","unstructured":"25th Annual Meeting of the Early Warning System Network. European Union Drugs Agency (EUDA); 2025."},{"key":"10.1016\/j.forsciint.2025.112794_bib7","article-title":"Etonitazepyne in counterfeit oxycodone tablets-a fatal case report","author":"Skarshaug","year":"2025","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112794_bib8","unstructured":"Narcotics and doping statistics 2024 (in Norwegian): The National Criminal Investigation Service (KRIPOS) 2025 [Available from: \u3008https:\/\/www.politiet.no\/globalassets\/tall-og-fakta\/narkotika\/narkotikastatistikk-2024.pdf\u3009."},{"key":"10.1016\/j.forsciint.2025.112794_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jchromb.2013.12.014","article-title":"Screening and quantitative determination of drugs of abuse in diluted urine by UPLC-MS\/MS","volume":"947-948","author":"Hegstad","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"6","key":"10.1016\/j.forsciint.2025.112794_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/jat\/bkaa016","article-title":"Isotonitazene quantitation and metabolite discovery in authentic forensic casework","volume":"44","author":"Krotulski","year":"2020","journal-title":"J. Anal. Toxicol."},{"issue":"6","key":"10.1016\/j.forsciint.2025.112794_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/15563650.2025.2504133","article-title":"Nitazenes: review of comparative pharmacology and antagonist action","volume":"63","author":"Stangeland","year":"2025","journal-title":"Clin. Toxicol. (Philos. )"},{"key":"10.1016\/j.forsciint.2025.112794_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110416","article-title":"Discriminative stimulus and antinociceptive effects of sixteen nitazene analogs in rodents","volume":"272","author":"Gatch","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.forsciint.2025.112794_bib13","doi-asserted-by":"crossref","first-page":"q2614","DOI":"10.1136\/bmj.q2614","article-title":"Deadly nitazenes: a 2024 update","volume":"387","author":"Nahar","year":"2024","journal-title":"Bmj"},{"key":"10.1016\/j.forsciint.2025.112794_bib14","unstructured":"The emergence of nitazenes in the America: Inter-American Drug Abuse Control Commission (CICAD); [Available from: \u3008https:\/\/www.oas.org\/ext\/DesktopModules\/MVC\/OASDnnModules\/Views\/Item\/Download.aspx?type=1&id=1045&lang=1\u3009."},{"issue":"4","key":"10.1016\/j.forsciint.2025.112794_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/PAF.0000000000000787","article-title":"Proliferation of novel synthetic opioids in postmortem investigations after core-structure scheduling for fentanyl-related substances","volume":"43","author":"Papsun","year":"2022","journal-title":"Am. J. Forensic Med. Pathol."},{"issue":"10","key":"10.1016\/j.forsciint.2025.112794_bib16","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/dta.3115","article-title":"Metonitazene in the United States\u2014Forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry","volume":"13","author":"Krotulski","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2025.112794_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/ckaf160","article-title":"The nitazene epidemic in Estonia: a first report","author":"Abel-Ollo","year":"2025","journal-title":"Eur. J. Public Health"},{"issue":"6","key":"10.1016\/j.forsciint.2025.112794_bib18","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00204-022-03276-4","article-title":"Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole \u2018nitazene\u2019 synthetic opioid","volume":"96","author":"Vandeputte","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112794_bib19","unstructured":"Emerging concerns and threats (FAQ drug-induced deaths in Europe): European Union Drugs Agency (EUDA); 2025 [Available from: \u3008https:\/\/www.euda.europa.eu\/publications\/topic-overviews\/drug-induced-deaths-faq\/emerging-concerns_en\u3009."},{"issue":"4","key":"10.1016\/j.forsciint.2025.112794_bib20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/FTD.0000000000000970","article-title":"Acute intoxications and fatalities associated with benzimidazole opioid (Nitazene Analog) use: a systematic review","volume":"44","author":"Montanari","year":"2022","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.forsciint.2025.112794_bib21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.21037\/apm.2019.12.09","article-title":"Combining opioids and benzodiazepines: effects on mortality and severe adverse respiratory events","volume":"9","author":"Boon","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.forsciint.2025.112794_bib22","unstructured":"About preliminary figures in the Cause of Death Register (in Norwegian): Norwegian Institute of Public Health; 2025 [Available from: \u3008https:\/\/www.fhi.no\/meldinger\/om-forelopige-tall-i-dodsarsaksregisteret\/\u3009."},{"key":"10.1016\/j.forsciint.2025.112794_bib23","unstructured":"Causes of death in Norway 2024 (in Norwegian): Norwegian Institute of Public Health, Cause of Death Register, Bergen; 2025 [Available from: \u3008https:\/\/www.fhi.no\/contentassets\/f0c4a47c54784e5bbad9cb2e3f675ffd\/rapport-dodsarsaksregisteret.pdf\u3009."},{"key":"10.1016\/j.forsciint.2025.112794_bib24","unstructured":"Increasing availability of nitazenes calls for global response: United Nations Office on Drugs and Crime (UNODC); [Available from: \u3008https:\/\/www.unodc.org\/LSS\/Announcement\/Details\/b47cf39e-f557-4001-98a8-536af5673e9e\u3009."},{"key":"10.1016\/j.forsciint.2025.112794_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109263","article-title":"Pharmacological characterization of novel synthetic opioids: isotonitazene, metonitazene, and piperidylthiambutene as potent \u03bc-opioid receptor agonists","volume":"221","author":"De Luca","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.forsciint.2025.112794_bib26","unstructured":"Local councils on the frontline: tackling nitazenes and drug-related deaths in England: Local Government Association; [Available from: \u3008https:\/\/www.local.gov.uk\/topics\/social-care-health-and-integration\/local-councils-frontline-tackling-nitazenes-and-drug\u3009."},{"issue":"3","key":"10.1016\/j.forsciint.2025.112794_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jat\/bkab117","article-title":"A forward-thinking approach to addressing the new synthetic Opioid 2-benzylbenzimidazole nitazene analogs by liquid chromatography\u2013tandem quadrupole mass spectrometry (LC\u2013QQQ-MS)","volume":"46","author":"Walton","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112794_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.legalmed.2023.102216","article-title":"Postmortem examination and toxicological analysis for acute metonitazene intoxication in Japan: a case report","volume":"61","author":"Morioka","year":"2023","journal-title":"Leg. Med."},{"issue":"9","key":"10.1016\/j.forsciint.2025.112794_bib29","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1007\/s00204-024-03774-7","article-title":"In vitro structure-activity relationships and forensic case series of emerging 2-benzylbenzimidazole 'nitazene' opioids","volume":"98","author":"De Vrieze","year":"2024","journal-title":"Arch. Toxicol."},{"issue":"7","key":"10.1016\/j.forsciint.2025.112794_bib30","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s00204-024-03735-0","article-title":"Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene","volume":"98","author":"Taoussi","year":"2024","journal-title":"Arch. Toxicol."},{"issue":"7","key":"10.1016\/j.forsciint.2025.112794_bib31","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acschemneuro.1c00064","article-title":"Synthesis, chemical characterization, and \u03bc-opioid receptor activity assessment of the emerging group of \u201cNitazene\u201d 2-Benzylbenzimidazole Synthetic Opioids","volume":"12","author":"Vandeputte","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.forsciint.2025.112794_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119764","article-title":"In vitro characterization of protonitazene metabolites, using human liver microsomes, and first application to two urines collected from death cases","volume":"561","author":"Ameline","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.forsciint.2025.112794_bib33","unstructured":"Critical review report. N-Pyrrolidino protonitazene (protonitazepyne) World Health Organisation (WHO). Expert Committee on Drug Dependence; 2024 [Available from: \u3008https:\/\/cdn.who.int\/media\/docs\/default-source\/controlled-substances\/47th-ecdd\/n-pyrrolidino-protonitazene-47th-ecdd-critical-review-public-version.pdf?sfvrsn=1d210d9_2\u3009."},{"key":"10.1016\/j.forsciint.2025.112794_bib34","unstructured":"New nitazene analogue N-pyrrolidino protonitazene impacting drug markets in North America and Europe: The Center for Forensic Science Research & Education (CFSRE); 2023 [Available from: \u3008https:\/\/www.cfsre.org\/images\/content\/reports\/public_alerts\/Public_Alert_N-Pyrrolidino_Protonitazene_230829AK.pdf\u3009."},{"issue":"5","key":"10.1016\/j.forsciint.2025.112794_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.annemergmed.2025.06.619","article-title":"Clinical experiences with the nitazene class of synthetic opioids: a cohort study","volume":"86","author":"Roberts","year":"2025","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.forsciint.2025.112794_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/s00414-025-03618-8","article-title":"A case of fatal intoxication with the novel synthetic opioid N-pyrrolidino protonitazene","author":"Wrbas","year":"2025","journal-title":"Int. J. Leg. Med."},{"issue":"2","key":"10.1016\/j.forsciint.2025.112794_bib37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40122-023-00481-6","article-title":"New synthetic opioids: clinical considerations and dangers","volume":"12","author":"Edinoff","year":"2023","journal-title":"Pain. Ther."},{"key":"10.1016\/j.forsciint.2025.112794_bib38","unstructured":"Critical review report: protonitazene. World Health Organisation. Expert Committee on Drug Dependence. 2022. [Available from: \u3008https:\/\/cdn.who.int\/media\/docs\/default-source\/controlled-substances\/45th-ecdd\/protonitazene_draft.pdf\u3009."},{"issue":"8","key":"10.1016\/j.forsciint.2025.112794_bib39","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1515\/cclm-2023-1360","article-title":"In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne)","volume":"62","author":"Berardinelli","year":"2024","journal-title":"Clin. Chem. Lab Med."},{"key":"10.1016\/j.forsciint.2025.112794_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.109999","article-title":"Distribution of synthetic opioids in postmortem blood, vitreous humor and brain","volume":"305","author":"Chesser","year":"2019","journal-title":"Forensic Sci. Int."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073825004384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073825004384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T23:45:02Z","timestamp":1770075902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073825004384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"alternative-id":["S0379073825004384"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2025.112794","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitazene-related deaths in Norway 2021\u20132024","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2025.112794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112794"}}